Inflammaging and Skeletal Muscle: Can Protein Intake Make a Difference?

Journal of Nutrition

Volumn 146, Issue 10, 2016, Pages

  Draganidis, Dimitrios ^a   Karagounis, Leonidas G ^a,d   Athanailidis, Ioannis ^b   Chatzinikolaou, Athanasios ^b   Jamurtas, Athanasios Z ^a,c   Fatouros, Ioannis G ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^d NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Frailty; Inflammaging; Oxidative stress; Skeletal muscle loss; Soy protein; Whey protein

Indexed keywords

ESSENTIAL AMINO ACID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; PROTEASOME; PROTEIN KINASE B; SOYBEAN PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ISOFLAVONE DERIVATIVE; MILK PROTEIN; MUSCLE PROTEIN; PROTEIN INTAKE; PROTEIN KINASE;

ADSORPTION KINETICS; AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DAIRY PRODUCT; DIET SUPPLEMENTATION; DOWN REGULATION; FRAIL ELDERLY; FUNCTIONAL DISEASE; HUMAN; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOSITIS; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN INTAKE; PROTEIN SYNTHESIS; RISK FACTOR; SIGNAL TRANSDUCTION; SKELETAL MUSCLE INFLAMMAGING; AGED; ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; INFLAMMATION; METABOLISM; MUSCULAR ATROPHY; PHARMACOLOGY; SKELETAL MUSCLE;

AGED; AGING; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHRONIC DISEASE; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DOWN-REGULATION; GLUTATHIONE; HUMANS; INFLAMMATION; ISOFLAVONES; MILK PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SOYBEAN PROTEINS;

EID: 84992724019     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.116.230912     Document Type: Article

References (118)

1. Waters DL, Baumqartner RN, Garry PJ, Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010;5:259-70.
2. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011;12:403-9.
3. Rennie MJ, Selby A, Atherton P, Smith K, Kumar V, Glover EL, Philips SM. Facts, noise and wishful thinking: muscle protein turnover in aging and human disuse atrophy. Scand JMed Sci Sports 2010;20:5-9.
4. McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res 2015;30:588-92.
5. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 2010;95:139-59.
6. Calçada D, Vianello D, Giampieri E, Sala C, Castellani G, de Graaf A, Kremer B, van Ommen B, Feskens E, Santoro A, et al. The role of lowgrade inflammation and metabolic flexibility in aging and nutritional modulation thereof: a systems biology approach. Mech Ageing Dev 2014;136-137:138-47.
7. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin NutrMetab Care 2012;15:12-22.
8. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007;292:R18-36.
9. Balage M, Averous J, Remond D, Bos C, Pujos-Guillot E, Papet I, Mosoni L, Combaret L, Dardevet D. Presence of low grade inflammation impaired postprandial stimulation of muscle protein synthesis in old rats. J Nutr Biochem 2010;21:325-31.
10. Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Payron MA, Combaret L, Dardevet D. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol 2009;587:5483-92.
11. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr 2003;78:250-8.
12. Wolfe RR, Miller S, Miller K. Optimal protein intake in the elderly. Clin Nutr 2008;27:675-84.
13. Bartali B, Frongillo EA, Stipanuk MH, Bandinelli S, Salvini S, Palli D, Morais JA, Volpato S, Guralnik JM, Ferrucci L. Protein intake and muscle strength in older persons: does inflammation matter? J Am Geriatr Soc 2012;60:480-4.
14. Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol 2009;107:987-92.
15. West DW, Burd NA, Coffey VG, Baker SK, Burke LM, Hawley JA, Moore DR, Stellingwerff T, Phillips SM. Rapid aminoacidemia enhances myofibrillar protein synthesis and anabolic intramuscular signaling responses after resistance exercise. Am J Clin Nutr 2011;94:795-803.
16. Burd NA, Yang Y, Moore DR, Tang JE, Tarnopolsky MA, Phillips SM. Greater stimulation of myofibrillar protein synthesis with ingestion of whey protein isolate v. micellar casein at rest and after resistance exercise in elderly men. Br J Nutr 2012;108:958-62.
17. Burris RL, Ng HP, Nagarajan S. Soy protein inhibits inflammationinduced VCAM-1 and inflammatory cytokine induction by inhibiting the NF-kB and AKT signaling pathway in apolipoprotein E-deficient mice. Eur J Nutr 2014;53:135-48.
18. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007;30:967-73.
19. Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci 2001;928:327-35.
20. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007;102:2389-97.
21. Li H, Malhorta S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) 2008;86:1113-26.
22. Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we age: insights into inflammaging. Longev Healthspan 2013;2:8.
23. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244-54.
24. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57:M326-32.
25. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119:526.e9-17.
26. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;64:1183-9.
27. Aleḿan H, Esparza J, Ramirez FA, Astiazaran H, Payette H. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing 2011;40:469-75.
28. Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad LW, Harris T. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham heart study. J Am Geriatr Soc 2003;51:1237-43.
29. Rohleder N, Kudielka BM, Hellhammer DH, Wolf JM, Kirschbaum C. Age and sex steroid-related changes in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. J Neuroimmunol 2002;126:69-77.
30. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639-46.
31. de Gonzalo-Calvo D, de Luxan-Delgado B, Rodriguez-Gonzalez S, Garcia-Macia M, Suarez FM, Solano JJ, Rodriguez-Colunga MJ, Coto-Montes A. Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach. Cytokine 2012;58:193-8.
32. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, et al. Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003;284:E481-7.
33. Bodell PW, Kodesh E, Haddad F, Zaldivar FP, Cooper DM, Adams GR. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 2009;106:443-53.
34. Trappe TA, Liu SZ. Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise. J Appl Physiol 2013;115:909-19.
35. Li YP, Reid MB. NF-kappa B mediates the protein loss induced by TNFalpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000;279:R1165-70.
36. Saini A, Al-Shanti N, Stewart CE. Waste management -cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 2006;17:475-86. Corrected and republished from: Cytokine Growth Factor Rev 2007;18(3-4):345.
37. Peterson JM, Bakkar N, Guttridge DC. NF-kB signaling in skeletal muscle health and disease. Curr Top Dev Biol 2011;96:85-119.
38. Chondrogianni N, Fragoulis EG, Gonos ES. Protein degradation during aging: the lysosome-and the proteasome-dependent cellular proteolytic systems. Biogerontology 2002;3:121-3.
39. Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES. Central role of the proteasome in senesce human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 2003;278:28026-37.
40. Chondrogianni N, Gonos ES. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology 2004;5:55-61.
41. Tanaka K, Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma inducible proteasome activator PA28. Immunol Rev 1998;163:161-76.
42. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999;68:1015-68.
43. Sandri M. Protein breakdown in muscle wasting: role of autophagylysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013;45:2121-9.
44. Löw P. The role of ubiquitin-proteasome system in ageing. Gen Comp Endocrinol 2011;172:39-43.
45. Llovera M, Lopez-Soriano FJ, Argiles JM. Effects of tumor necrosis factoralpha on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst 1993;85:1334-9.
46. Ling PR, Schwartz JH, Bistrian BR. Mechanisms of host wasting induced by administration of cytokines in rats. Am J Physiol 1997;272:E333-9.
47. Mayot G, Breuille D, Jarret AR, Obled C, Papet I. Systemic low-grade inflammation does not decrease skeletal muscle mass and protein synthesis in old rats. JMusculoskelet Neuronal Interact 2008;8:410-7.
48. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005;98:911-7.
49. van Hall G, Steensberg A, Fischer C, Keller C, Moller K, Moseley P, Pedersen BK. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 2008;93:2851-8.
50. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, Wackerhage H, Taylor PM, Rennie MJ. Anabolic signaling deficits underline amino acid resistance of wasting, aging muscle. FASEB J 2005;19:422-4.
51. Rivas DA, Morris EP, Haran PH, Pasha EP, Morais Mda S, Dolnikowski GG, Phillips EM, Fielding RA. Increased ceramide content and NFkB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males. J Appl Physiol 2012;113:1727-36.
52. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-a induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005;54:2939-45.
53. Hyldahl RD, Olson T, Welling T, Groscost L, Parcell AC. Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Front Physiol 2014;5:485.
54. Farup J, Rahbek SK, Knudsen IS, de Paoli F, Mackey AL, Vissing K. Whey protein supplementation accelerates satellite cell proliferation during recovery from eccentric exercise. Amino Acids 2014;46:2503-16.
55. Beenakker KG, Duijnisveld BJ, Van Der Lindeen HM, Visser CP, Westendorp RG, Butler-Brown G, Nelissen RG, Maier AB. Muscle characteristics in patients with chronic inflammation. Muscle Nerve 2012;46:204-9.
56. Wolfe RR. The role of dietary protein in optimizing muscle mass, function and health outcomes in older individuals. Br J Nutr 2012;108:S88-93.
57. Pennings B, Groen B, de Lange A, Gijsen AP, Zorenc AH, Senden JMG, van Loon LJC. Amino acid absorption and subsequent muscle protein accretion following graded intakes of whey protein in elderly men. Am J Physiol Endocrinol Metab 2012;302:E992-9.
58. Tipton KD, Rasmussen BB, Miller SL, Wolfe SE, Owens-Stovall SK, Petrini BE, Wolfe RR. Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. Am J Physiol Endocrinol Metab 2001;281:E197-206.
59. Koopman R, Gleeson BG, Gijsen AP, Groen B, Senden JM, Rennie MJ, van Loon LJ. Post-exercise protein synthesis rates are only marginally higher in type I compared with type II muscle fibers following resistance-type exercise. Eur J Appl Physiol 2011;111:1871-8.
60. Moore DR. Keeping older muscle ''young'' through dietary protein and physical activity. Adv Nutr 2014;5:599S-607S.
61. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:391-6.
62. Moore DR, Churchward-Venne TA, Witard O, Breen L, Burd NA, Tipton KD, Phillips SM. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci 2015;70:57-62.
63. Wall BT, Gorissen SH, Pennings B, Koopman R, Groen BB, Verdijk LB, van Loon LJ. Aging is accompanied by a blunted protein synthetic response to protein ingestion. PLoS One 2015;11:e0140903.
64. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging 2008;12:452-6.
65. Volpi E, Campbell WW, Dwyer JT, Johnson MA, Jensen GL, Morley JE, Wolfe RR. Is the optimal level of protein intake for older adults greater than the recommended dietary allowance? J Gerontol A Biol Sci Med Sci 2013;68:677-81.
66. Houston DK, Nicklas BJ, Ding J, Harris TB, Tylavsky FA, Newman AB, Lee JS, Sahyoun NR, Visser M, Kritchevsky SB, et al. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr 2008;87:150-5.
67. McCarty MF, DiNicolantonio JJ. An increased need for dietary cysteine in support of glutathione synthesis may underline the increased risk for mortality associated with low protein intake in the elderly. Age (Dordr) 2015;37:96.
68. Xu R, Liu N, Xu X, Kong B. Antioxidant effects of whey protein on peroxide-induced cytotoxicity. J Dairy Sci 2011;94:3739-46.
69. Jin MM, Zhang L, Yu HX, Meng J, Sun Z, Lu RR. Protective effect of whey protein hydrolysates on H2O2-induced PC12 cells oxidative stress via a mitochondrial-mediated pathway. Food Chem 2013;141:847-52.
70. Kerasioti E, Stagos D, Priftis A, Aivazidis S, Tsatsakis AM, Hayes AW, Kouretas D. Antioxidant effects of whey protein on muscle C2C12 cells. Food Chem 2014;155:271-8.
71. Athira S, Mann B, Sharma R, Kumar R. Ameliorative potential of whey protein hydrolysate against paracetamol-induced oxidative stress. J Dairy Sci 2013;96:1431-7.
72. Kim J, Paik HD, Yoon YC, Park E. Whey protein inhibits iron overload-induced oxidative stress in rats. J Nutr Sci Vitaminol (Tokyo) 2013;59:198-205.
73. Ebaid H, Salem A, Sayed A, Metwalli A. Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats. Lipids Health Dis 2011;10:235.
74. Nelson AR, Jackson L, Clarke J, Stellingwerff T, Broadbent S, Rowlands DS. Effect of post-exercise protein-leucine feeding on neutrophil function, immunomodulatory plasma metabolites and cortisol during a 6-day block of intense cycling. Eur J Appl Physiol 2013;113:2211-22.
75. Rowlands DS, Rossler K, Thorp RM, Graham DF, Timmons BW, Stannard SR, Tarnopolsky MA. Effect of dietary protein content during recovery from high-intensity cycling on subsequent performance and markers of stress, inflammation, and muscle damage in well-trained men. Appl Physiol Nutr Metab 2008;33:39-51.
76. Brown EC, DiSilvestro RA, Babaknia A, Devor ST. Soy versus whey protein bars: effects on exercise training impact on lean body mass and antioxidant status. Nutr J 2004;3:22.
77. Kerasioti E, Kiskini A, Veskoukis A, Jamurtas A, Tsitsimpikou C, Tsatsakis AM, Koutedakis Y, Stagos D, Kouretas D, Karathanos V. Effect of a special carbohydrate-protein cake on oxidative stress markers after exhaustive cycling in humans. Food Chem Toxicol 2012;50:2805-10.
78. Kerasioti E, Stagos D, Jamurtas A, Kiskini A, Koutedakis Y, Goutzoulas N, Pournaras S, Tsatsakis AM, Kouretas D. Antiinflammatory effects of a special carbohydrate-whey protein cake after exhaustive cycling in humans. Food Chem Toxicol 2013;61:42-6.
79. Samaras A, Tsarouhas K, Paschalidis E, Giamouzis G, Triposkiadis F, Tsitsimpikou C, Becker AT, Goutzourelas N, Kouretas D. Effect of a special carbohydrate-protein bar and tomato juice supplementation on oxidative stress markers and vascular endothelial dynamics in ultramarathon runners. Food Chem Toxicol 2014;69:231-6.
80. Pal S, Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity (Silver Spring) 2010;18:1354-9.
81. Pal S, Ellis V. Acute effects of whey protein isolate on blood pressure, vascular function and inflammatory markers in overweight postmenopausal women. Br J Nutr 2011;105:1512-9.
82. Zemel MB, Sun X, Sobhani T, Wilson B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 2010;91:16-22.
83. Holmer-Jensen J, Karhu T, Mortensen LS, Pedersen SB, Herzig KH, Hermansen K. Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects. Nutr J 2011;10:115.
84. Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003;2:195-8.
85. Michailidis Y, Karagounis LG, Terzis G, Jamurtas AZ, Spengos K, Tsoukas D, Chatzinikolaou A, Mandalidis D, Stefanetti RJ, Papassotiriou I, et al. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am J Clin Nutr 2013;98:233-45.
86. Chatzinikolaou A, Christoforidis C, Avloniti A, Draganidis D, Jamurtas AZ, Stampoulis T, Ermidis G, Sovatzidis A, Papassotiriou I, Kambas A, et al. A microcycle of inflammation following a team handball game. J Strength Cond Res 2014;28:1981-94.
87. Barbas I, Fatouros IG, Douroudos II, Chatzinikolaou A, Michailidis Y, Draganidis D, Jamurtas AZ, Nikolaidis MG, Parotsidis C, Theodorou AA, et al. Physiological and performance adaptations of elite Greco-Roman wrestlers during a one-day tournament. Eur J Appl Physiol 2011;111:1421-36.
88. Morrison D, Hughes J, Della Gatta PA, Mason S, Lamon S, Russell AP, Wadley GD. Vitamin C and E supplementation prevents some of the cellular adaptations to endurance-training in humans. Free Radic Biol Med 2015;89:852-62.
89. Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr 2008;138:1244S-9S.
90. Aoki H, Otaka Y, Igarashi K, Takenaka A. Soy protein reduces paraquat-induced oxidative stress in rats. J Nutr 2002;132:2258-62.
91. Takenaka A, Annaka H, Kimura Y, Aoki H, Igarashi I. Reduction of paraquat-induced oxidative stress in rats by dietary soy peptide. Biosci Biotechnol Biochem 2003;67:278-83.
92. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Ben-Ami M. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 2003;145:e7.
93. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
94. Yoon GA, Park S. Antioxidant action of soy isoflavones on oxidative stress and antioxidant enzyme activities in exercised rats. Nutr Res Pract 2014;8:618-24.
95. Sankar P, Zachariah B, Vickneshwaran V, Jacob SE, Sridhar MG. Amelioration of oxidative stress and insulin resistance by soy isoflavones (from Glycine max) in ovariectomized Wistar rats fed with high fat diet: the molecular mechanisms. Exp Gerontol 2015;63:67-75.
96. Park E, Shin JI, Park OJ, Kang MH. Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 2005;51:254-9.
97. Hsieh HM, Wu WM, Hu ML. Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with D-galactose. Food Chem Toxicol 2009;47:625-32.
98. Djuric Z, Chen G, Doerge DR, Heilbrum LK, Kucuk O. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett 2001;172:1-6.
99. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 2006;83:1118-25.
100. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76 rodent diet. J Nutr 1993;123:1939e51.
101. Hagen MK, Lehenbauer-Luke AR, Paludo AC, Schenkel P, Goncalves L, Fernandes TG, Caron R, Llesuy S,Mill JG, Bello-Klein A. Diet with isolated soy protein reduces oxidative stress and preserves ventricular function in rats with myocardial infarction. Nutr Metab Cardiovasc Dis 2009;19:91-7.
102. Sreeja S, Geetha R, Priyadarshini E, Bhavani K, Anuradha CV. Substitution of soy protein for casein prevents oxidative modification and inflammatory response induced in rats fed high fructose diet. ISRN Inflamm 2014;2014:641096.
103. Messina S, Bitto A, Aguennouz M, Vita GL, Polito F, Irrena N, Altavilla D, Marini H, Migliorato A, Sguadrito F, et al. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNFa activation and ameliorates muscle function and morphology in mdx mice. Neuromuscul Disord 2011;21:579-89.
104. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 2008;62:1419-25.
105. Törmälä R, Appt S, Clarkson TB, Mueck AO, Seeger H, Mikkola TS, Ylikorkala O. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability. Climacteric 2008;11:409-15.
106. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism 2015;64:236-43.
107. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 2008;102:84-6.
108. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 2003;78:123-30.
109. Sirtori CR, Lovati MR. Soy proteins and cardiovascular disease. Curr Atheroscler Rep 2001;3:47-53.
110. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acutephase reactants. Nephrol Dial Transplant 2006;21:2239-46.
111. Mangano KM, Hutchins-Wiese HL, Kenny AM, Walsh SJ, Abourizk RH, Bruno RS, Lipcius R, Fall P, Kleppinger A, Kenyon-Pesce L, et al. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial. Nutr Res 2013;33:1026-33.
112. Swain JH, Alekel DL, Dent SB, Peterson CT, Reddy MB. Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women. Am J Clin Nutr 2002;76:165-71.
113. Thomson RL, Brinkworth GD, Noakes M, Buckley JD. Muscle strength gains during resistance exercise training are attenuated with soy compared with dairy or usual protein intake in older adults: A randomized controlled trial. Clin Nutr 2016;35:27-33.
114. Vega-López S, Yeum KJ, Lecker JL, Ausman LM, Johnson EJ, Devaraj S, Jialal I, Lichtenstein AH. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr 2005;81:43-9.
115. Beavers KM, Serra MC, Beavers DP, Cooke MB, Willoughby DS. Soymilk supplementation does not alter plasma markers of inflammation and oxidative stress in postmenopausal women. Nutr Res 2009;29:616-22.
116. Miraghajani MS, Esmaillzadeh A, Najafabadi MM, Mirlohi M, Azadbakht L. Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy. Diabetes Care 2012;35:1981-5.
117. Mitchell JH, Collins AR. Effects of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men-a pilot study. Eur J Nutr 1999;38:143-8.
118. Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner D, Vidgen E. Effects of high-and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 2002;51:919-24.